- Perimenopause
You have always known yourself. Your rhythms, your reactions, your emotional baseline.
Then something shifted.
Maybe it was anxiety that arrived without a clear trigger. Maybe it was irritability so out of proportion to the situation that it surprised even you. Maybe it was a flatness, a dimming of things that used to feel meaningful, that you could not quite explain.
Maybe it was the brain fog: the word that vanished mid-sentence, the thought you could not hold onto, the sense that your mind was moving through something thicker than air.
Silently, maybe you wondered whether something was wrong with you. Whether this was depression. Whether this was who you were becoming.
I want to address that directly: what you are describing is one of the most common and least discussed experiences of perimenopause. It is not a character change. It is not a psychiatric disorder. It is estrogen and the specific, physiologically coherent way that estrogen interacts with the brain.
Understanding that interaction changes everything.
The word “estrogen” tends to conjure images of reproduction: cycles, pregnancy, fertility. That framing is accurate as far as it goes, but it is profoundly incomplete.
Estrogen receptors exist throughout the brain. They are particularly dense in the regions responsible for mood regulation, stress response, cognitive function, and emotional processing. The hippocampus is critical for memory and learning. The prefrontal cortex is responsible for executive function, planning, and emotional regulation. The amygdala is the brain’s threat-detection center.
Estrogen does not just influence these regions. It actively supports their function. It promotes the production and activity of serotonin, the neurotransmitter most associated with mood stability. It supports dopamine pathways involved in motivation and reward. It modulates the stress hormone cortisol. It influences GABA, the brain’s primary calming neurotransmitter.
When estrogen levels are stable, all of this happens quietly in the background. You feel like yourself.
When estrogen becomes erratic, as it does in perimenopause, the neurological effects are not quiet at all.
Perimenopause is not a state of steadily declining estrogen. It is a state of estrogen variability including unpredictable surges and drops that can occur within a single cycle and differ dramatically from one month to the next.
For the brain, this variability is profoundly disruptive.
Mood Instability and Emotional Reactivity
When estrogen drops sharply, serotonin production is affected. The result is not necessarily clinical depression. Although perimenopause does increase the risk of depressive episodes, particularly in women with prior history of mood disorders. The more common experience is a mood that feels unreliable: reactive, brittle, harder to regulate than it used to be.
Situations that would previously have been manageable feel overwhelming. Emotional responses feel out of proportion. The recovery time after a stressful event feels longer than it once did.
This is not overreaction. This is a brain operating with reduced serotonergic support during a period of hormonal fluctuation.
Anxiety
New or worsening anxiety is one of the most frequently reported and least explained perimenopause symptoms. Women who have never experienced significant anxiety describe its sudden arrival in their 40s as deeply disorienting.
The physiological explanation involves estrogen’s relationship with both cortisol and GABA. Estrogen normally helps modulate cortisol, the body’s primary stress hormone. When estrogen drops, cortisol regulation is less precise — and the physiological experience of stress can intensify. Simultaneously, estrogen’s support of GABA pathways is reduced, and GABA is precisely what helps the nervous system down-regulate from a state of arousal.
The result: a nervous system that activates more easily and calms down more slowly. That is anxiety, described physiologically.
Brain Fog and Cognitive Changes
Perhaps no perimenopausal symptom generates more distress than cognitive changes. Women describe struggling to find words, difficulty concentrating, memory lapses that feel unlike anything they’ve experienced before, a sense that they cannot think as clearly or as quickly as they could.
This is real, it is documented, and it is neurologically explicable.
Estrogen supports cerebral blood flow, the delivery of oxygen and glucose to the brain. It has neuroprotective properties, supporting the health and connectivity of neurons. It influences the acetylcholine system involved in attention and memory.
During the erratic estrogen fluctuations of perimenopause, cognitive function can feel inconsistent from week to week: sometimes clear, sometimes frustratingly clouded.
The research on perimenopausal cognitive changes is reassuring in one important respect: for most women, the brain fog of perimenopause is temporary. Cognitive function tends to stabilize after the menopausal transition is complete. This is not dementia. It is a transitional phase with a physiological cause.
One of the most useful things to understand about perimenopausal mood and cognitive changes is that they often follow a pattern even when cycles themselves have become irregular.
Many women notice that mood and cognitive symptoms are worst in the week before a period, in the days immediately following a drop in progesterone and estrogen. They may notice that the week or so after a period begins brings some relief. This cyclical pattern which is familiar to women who have experienced significant PMS, often becomes more pronounced in perimenopause as hormonal fluctuations grow more extreme.
Tracking this pattern is genuinely useful. It helps distinguish perimenopausal mood changes from free-floating anxiety or depression. It provides language for clinical conversations, and it restores a sense of coherence to experiences that can otherwise feel random and disturbing.
Perimenopause increases the risk of clinical depression. This is important to name clearly, because dismissing perimenopausal mood symptoms as “just hormones” can lead to undertreatment of a condition that warrants clinical attention.
At the same time, perimenopausal mood changes are not automatically depression. The distinction matters because the treatments differ, and because many women are offered antidepressants for symptoms that are primarily hormonal in origin — without anyone explaining the underlying physiology or exploring hormonal management as part of the clinical picture.
A few questions worth discussing with a clinician:
– Are the mood changes cyclical or relatively constant?
– When did they start relative to cycle changes?
– Are they accompanied by other perimenopausal symptoms — sleep disruption, vasomotor symptoms, cycle irregularity?
– Is there a personal or family history of mood disorders, particularly premenstrual dysphoric disorder (PMDD)?
These questions help clarify whether mood changes are primarily hormonal, primarily psychiatric, or both which is also possible, and common.
The clinical options for perimenopausal mood and cognitive symptoms are broader than many women realize, and the conversation with a clinician is more nuanced than it is often presented.
Hormonal management, particularly low-dose estrogen therapy, has evidence supporting its effectiveness for mood stability and cognitive symptoms during perimenopause, particularly for women whose symptoms began in the context of hormonal changes. This is distinct from the use of antidepressants, which may also be appropriate depending on the clinical picture.
Non-hormonal approaches with meaningful evidence include regular aerobic exercise, which supports serotonin production and has been studied specifically in the context of perimenopausal mood; sleep optimization, which is its own challenge in perimenopause but has a profound effect on mood stability; and cognitive behavioral therapy approaches adapted for perimenopause-related anxiety.
The most important thing you can do is name these symptoms explicitly in a clinical conversation and know that they are a legitimate part of the perimenopausal picture, not a separate problem to be embarrassed about.
The Clarity Perimenopause learning path includes a dedicated section on the brain and emotional experience of perimenopause — covering the neuroscience of estrogen’s effects on mood and cognition, the evidence base for different interventions, and the specific language to use in a clinical conversation about mood and cognitive symptoms.
It also includes a My Care Conversation Guide specifically structured to help you bring these experiences to a clinician in a way that is heard and addressed.
Learn more about the MyClarity Perimenopause learning path
—
April Lind, MD is a physician and the founder of MyClarity, a women’s health education platform. This article is for educational purposes only and does not constitute medical advice. If you are experiencing mood changes or cognitive symptoms that concern you, please consult a qualified healthcare provider.
Dr. April Lind, Founder of MyClarity
As a physician in women’s health, I have spent years caring for women across life stages – adolescence, pregnancy, postpartum, infertility and into midlife. I created MyClarity because women deserve to understand what is happening in their bodies before they are told what to do about it.
Join my mailing list and receive new posts directly to your inbox.
